SATB1 is required for CD8 coreceptor reversal.

Molecular Immunology
Hui NieP W Tucker

Abstract

Intrathymic signals induce the differentiation of immature CD4(+)CD8(+) double positive (DP) thymocytes into mature CD4(+) or CD8(+) single positive (SP) T cells. The transcriptional mechanism by which CD8 lineage is determined is not fully understood. The best evidence, which favors the kinetic signaling/coreceptor reversal model, indicates that signaled DP thymocytes terminate CD8 transcription prior to their subsequent re-initiation of CD8 transcription and ultimate differentiation into CD8SP T cells. We and others have shown that CD8 lineage commitment is severely perturbed in mice in which expression of the transcription factor SATB1 is either conventionally knocked out or T cell-specifically knocked down. Here, we demonstrate that, as with normal thymocytes, cultured SATB1-deficient DP thymocytes inactivate CD8 coreceptor transcription following receipt of signals (PMA plus ionomycin) that mimic TCR-mediated positive selection. However, this terminated CD8 transcription is not re-initiated by signals (IL-7) conducive to CD8 differentiation in SATB1-deficient DP. We show that SATB1 specifically binds to a cis-regulatory element within the CD8 enhancer (E8(III)) known to be required for coreceptor reversal. A requirement in...Continue Reading

References

Sep 1, 1993·The Journal of Experimental Medicine·D B LandryR Sen
Apr 25, 1997·The Journal of Biological Chemistry·L A DickinsonT Kohwi-Shigematsu
Jul 12, 2002·Nature·Tian H ChiGerald R Crabtree
Oct 11, 2002·Nature·Dag YasuiTerumi Kohwi-Shigematsu
Apr 27, 2005·The Journal of Biological Chemistry·Jin SeoJaquelin P Dudley

❮ Previous
Next ❯

Citations

Jun 25, 2013·Cellular and Molecular Life Sciences : CMLS·Wilfried EllmeierRoland Tschismarov
Aug 1, 2009·Cancer Cell International·Neill PataniKefah Mokbel
Jan 8, 2014·Cancer Biotherapy & Radiopharmaceuticals·Lei ZhangJianfang Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.